Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$67.01 Mil
% of Total Estimate Gain
165.86%

BAKER BROS. ADVISORS LP's Krystal Biotech Inc Holding Summary

As of 2025-03-31, BAKER BROS. ADVISORS LP held - shares of Krystal Biotech Inc(KRYS), totaling N/A. This investment constitutes 0% of their stock portfolio, and BAKER BROS. ADVISORS LP now holds 0% of the outstanding Krystal Biotech Inc(KRYS) stock.

The initial trade took place in 2017Q3. And since then BAKER BROS. ADVISORS LP has made 5 purchases of KRYS, at an average price of $29.25, for a total of 1.38 Mil shares. In addition, there have been 10 sales at an average price of $77.75 for 1.38 Mil shares. Based on historical transaction data and KRYS's current price of $138.88, BAKER BROS. ADVISORS LP's estimated gain on his KRYS holdings is $67.01 Mil, reflecting a 165.86% gain to date.

BAKER BROS. ADVISORS LP KRYS ($138.88) Holding Chart

BAKER BROS. ADVISORS LP KRYS ($138.88) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1